Peptide discovery
Send only your best peptides to the lab
Design peptide binders, check cleavage and immunogenicity risk, and model how they sit on the target before synthesis.
Trusted by 16,500+ researchers and published in
Generate candidates
Generate peptide binders from the target with several methods, including cyclic and mimetic designs, and keep each method’s native ranking and output files.
Check sequences for proteolysis
Calculate mass, charge and isoelectric point, then map protease cleavage sites to see which candidates would be cut up before they reach the target.
Screen immunogenicity and developability
Compare immunogenicity, solubility, stability and aggregation risk across your shortlist, so the peptides you take forward are the least likely to cause trouble.
Peptide discovery use cases
Pick the method that fits your question and evidence. Each one comes with a workflow you can open and edit.
Peptide design
Generate compact peptide candidates for a target or property objective, then screen activity and developability signals.
Peptide structure prediction
Predict plausible peptide conformations while preserving cyclization, sequence length, flexibility, and model-specific structural assumptions.
Peptide–protein docking
Model flexible peptide binding poses against prepared protein receptors and compare alternative interaction hypotheses.
Protein structure prediction
Fold a protein sequence online with AlphaFold2 or ESMFold, predict complexes with ligands or nucleic acids using Boltz-2 or Chai-1, and see which regions each model is confident about.
Guides for peptide work
Background guides on the methods, scores, and numbers behind these workflows.

Proteins · 15 min
How much does peptide synthesis cost?
Custom peptides cost about $2 to $4.50 per amino acid crude and about $12 at over 95% purity. See how purity, length, scale and modifications change the price.

Structures · 17 min
What is pLDDT, and what counts as a good score
pLDDT is the per-residue confidence score that AlphaFold, ESMFold and Boltz attach to predicted structures. Learn what the 90, 70 and 50 cutoffs mean and why neither a high nor a low score settles whether a region is real.

Structures · 15 min
ipTM vs pTM: judging predicted complexes
pTM scores the whole predicted structure, while ipTM scores only how chains sit relative to each other. Learn what the 0.5, 0.6 and 0.8 cutoffs mean and why disordered tails lower ipTM.

Drugs · 16 min
How many peptide drugs are FDA approved?
The FDA has approved 98 peptide drugs of 2 to 50 amino acids, and 77 are still marketed in the US. Leaving out antibiotics made by microbes gives 79; adding the insulins gives 106. Full list, GLP-1 family and free CSV, checked October 29, 2026.

Proteins · 16 min
Protein aggregation: causes, prediction and prevention
Protein aggregation is the self-association of protein molecules into amorphous clumps, soluble oligomers or ordered amyloid fibrils. Learn why proteins aggregate, how aggregates are measured, what TANGO, AGGRESCAN, CamSol, Aggrescan3D, Protein-Sol and NetSolP predict from sequence and structure, and how formulation, mutations and expression conditions prevent it, with a worked Aggrescan3D run on transthyretin.
FAQs
ProteinIQ helps keep those signals together before laboratory testing. You can design or import peptides, calculate sequence properties, screen activity-related predictions, model structures, and compare the resulting tables and files without losing the relationship to each candidate. Start with a peptide sequence, a target, or a candidate library and run the checks needed for your decision. ProteinIQ returns the method-specific scores, structures, logs, and exports so a shortlist can be reviewed with its supporting evidence intact.
ProteinIQ supports peptide discovery workflows for sequence design, peptide property calculation, cleavage analysis, activity prediction, solubility review, immunogenicity-style triage, and structure follow-up. You can use these workflows to move from candidate sequences to reviewable computational evidence without writing local scripts.
ProteinIQ peptide tools commonly start from raw peptide sequences or FASTA records. Structure follow-up tools may require protein-style FASTA inputs or existing structure files, and each ProteinIQ workflow keeps those input requirements tied to the upstream tool being run.
Yes. ProteinIQ can run peptide design tools that generate candidate sequences, then route those candidates into property, activity, solubility, cleavage, and structure checks. The generated peptides should be treated as computational candidates for prioritization, not as experimentally validated hits.
ProteinIQ can help review peptide activity and liability signals such as antimicrobial or functional activity predictions, cleavage behavior, sequence properties, and developability-related descriptors when supported by the selected tool. The platform keeps the prediction labels and score tables visible so researchers can compare candidates directly.
ProteinIQ peptide property tools can calculate descriptors such as mass, charge, composition, cleavage products, hydropathy, and related sequence features depending on the tool. These calculations are presented as inspectable tables and downloads so the peptide sequence remains connected to the property evidence.
Yes. ProteinIQ can route peptide or short protein sequences into compatible structure prediction and modeling tools when the upstream method supports the input. Structure outputs can include PDB or CIF files, confidence information, logs, and other artifacts for downstream review.
Yes. ProteinIQ peptide workflows are useful when you want connected design, property, activity, and structure checks, but individual tools such as peptide mass, peptide cleavage, activity prediction, and folding tools can also be opened directly for a narrower question.
Yes. ProteinIQ peptide workflows can export FASTA sequences, generated candidate lists, CSV property tables, activity prediction tables, structure files, logs, and upstream result artifacts depending on the tool. Exports are intended to keep the computational evidence available for review outside ProteinIQ.
No. ProteinIQ provides computational peptide discovery and prioritization evidence. Experimental activity, toxicity, stability, permeability, immunogenicity, and developability assays are still required before making biological, therapeutic, or product claims about a peptide candidate.
AI answers from our docs. No sign-in needed.
Focus on research, not infrastructure
Start free with 200 credits a month and no installs. Upgrade when your project needs more compute.